ANT BIO PTE. LTD. Literature Review: Park7/DJ‑1 Recombinant Rabbit Monoclonal Antibody in Regulating Myocardial Hypertrophy

Literature Information

Topic: Regulatory Mechanisms of Park7/DJ‑1 in Pathological Myocardial Hypertrophy and Application of Recombinant Rabbit Monoclonal Antibodies

Core Content: Park7/DJ‑1 maintains mitochondrial homeostasis, suppresses oxidative stress, and inhibits myocardial hypertrophy via the PSMB10‑ATRAP‑AT1R axis. Recombinant rabbit monoclonal antibodies enable high‑precision detection of Park7/DJ‑1 expression, localization, and interaction networks.

Research Focus: Cardiovascular protection, mitochondrial quality control, antibody-based detection, and translational research.

Research Background

Pathological myocardial hypertrophy is a key precursor to heart failure, driven by oxidative stress, mitochondrial dysfunction, and aberrant signaling cascades. Park7/DJ‑1 acts as a critical antioxidant and cytoprotective protein that maintains cardiomyocyte homeostasis. Reliable research tools are essential to characterize its molecular functions and therapeutic potential.

Research Ideas

1. Define the cytoprotective roles of Park7/DJ‑1 in myocardial hypertrophy.
2. Characterize the molecular pathways by which Park7/DJ‑1 preserves mitochondrial function.
3. Elucidate the signaling cascade: Park7/DJ‑1 → PSMB10 → ATRAP → AT1R.
4. Validate the performance of recombinant rabbit monoclonal antibodies for detecting endogenous Park7/DJ‑1.
5. Demonstrate the utility of ANT BIO PTE. LTD. reagents in cardiovascular research.

Research Outcomes

• Park7/DJ‑1 mitigates myocardial hypertrophy by reducing mitochondrial ROS, stabilizing membrane potential, and promoting mitophagy and mitochondrial biogenesis.
• Park7/DJ‑1 binds and inhibits PSMB10, stabilizing ATRAP to negatively regulate AT1R signaling.
• Recombinant rabbit monoclonal antibodies against Park7/DJ‑1 exhibit high affinity, specificity, and batch‑to‑batch consistency.
• These antibodies are widely applicable in WB, IP, IHC, IF, and flow cytometry.
• Park7/DJ‑1 represents a promising diagnostic marker and therapeutic target for cardiac diseases.

Product Empowerment by ANT BIO PTE. LTD.

ANT BIO PTE. LTD. provides high-performance recombinant rabbit monoclonal antibodies against Park7/DJ‑1 under the Starter product line. These antibodies enable:

• Specific and sensitive detection of Park7/DJ‑1 protein in tissues and cells.
• Reliable quantification of Park7/DJ‑1 expression in hypertrophy models.
• Investigation of protein interactions involving Park7/DJ‑1, PSMB10, and ATRAP.
• Reproducible data for mechanistic and translational studies.

Absin provides supporting buffers, kits, and reagents for immunoassays.

UA provides recombinant proteins for pathway validation and functional assays.

Brand Mission

ANT BIO PTE. LTD. is a leading provider of life science reagents, including antibodies, proteins, and kits. Our three specialized brands serve focused research areas:

• Absin: General reagents and kits
• Starter: Antibodies
• UA: Recombinant proteins

We support global research in cardiovascular science, neurodegeneration, oncology, and immunology with innovative, reliable tools.

Related Product List

• Park7/DJ‑1 recombinant rabbit monoclonal antibody
• PSMB10 antibody
• ATRAP antibody
• AT1R antibody
• Mitochondrial function assay kits
• Oxidative stress detection kits
• WB/IP/IHC supporting reagents and kits

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights